Cigna Corporation

NYSE:CI

312.9 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 247,121195,187180,031174,267160,550153,74348,56942,04340,00737,87634,91432,38029,11921,99821,25318,41419,10117,62316,54716,68418,17618,80819,34819,11519,99418,78121,43720,03818,95018,95518,39213,71213,92414,29513,98611,4940000
Cost of Revenue 0000000000000000000000000000000000000000
Gross Profit 247,12100000000000021,99821,25318,41419,10117,62316,54716,68418,17618,80819,34819,11519,99418,78121,43720,03818,95018,95518,39213,71213,92414,29513,98611,4940000
Gross Profit Ratio 100.82200.7960.80.433111111111111111111111111111110000
Reseach & Development Expenses 0000000000000000000000000000000000000000
General & Administrative Expenses 00000000000005,9015,7445,4505,53500000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 14,84414,37013,11012,79113,66013,31511,1419,8309,75000005,9015,7445,4505,53500000000000000000000000
Other Expenses 229,540172,281158,471153,535138,737132,35133,26828,27127,169000014,08813,58211,06613,18415,99014,81614,891-15,940-17,905-19,918-17,618-18,497-16,487-19,427-18,388-17,349-18,704-17,587-13,547-13,771-13,715-13,622-10,798570.1833700.9-854.9
Operating Expenses 244,384186,651171,581166,326152,397145,66644,40938,10136,91900026,37419,98919,32616,51618,71915,99014,81614,891-15,940-17,905-19,918-17,618-18,497-16,487-19,427-18,388-17,349-18,704-17,587-13,547-13,771-13,715-13,622-10,798570.1833700.9-854.9
Operating Income 9,4178,5368,4507,9418,1538,0774,1603,9423,08837,87634,91432,3802,8752,1692,0481,8963821,6261,7311,7932,236903-5701,4971,4972,2942,0101,6501,601251805165153580364696570.1833700.9-854.9
Operating Income Ratio 0.0380.0440.0530.0480.054-0.6280.0840.1030.0760.0880.0950.0670.0850.0990.0960.1030.020.0920.1050.1070.1230.048-0.0290.0780.0750.1220.0940.0820.0840.0130.0440.0120.0110.0410.0260.0610000
Total Other Income Expenses Net -4,148-3,023-53-1,1512,715-1,507-579-336-109-34,549-31,610-30,204-398-63-257-421-16200-193-55-569001,2191,85801,601251805000000000
Income Before Tax 5,2695,5138,3976,79010,8686,5703,5813,6062,9793,3273,3042,1762,4771,9681,8701,8983781,6311,7311,7932,375903-5691,4971,4971,2192,0101,6501,601251805000000000
Income Before Tax Ratio 0.0210.0280.0460.0390.0680.0430.0740.0860.0750.0880.0950.0670.0850.0890.0880.1030.020.0930.1050.1070.1310.048-0.0290.0780.0750.0650.0940.0820.0840.0130.044000000000
Income Tax Expense 4,9251411,6151,3702,3791,4509351,3741,1361,2501,21069885364052159490511572517798283-17250851052071856454540251-69-1581313413497.9147.4166-0.3
Net Income 3445,1646,7045,3708,4585,1042,6372,2371,8672,0942,1021,4761,6231,3271,3451,3022921,1151,1551,6251,438668-3989899871,7741,2921,0861,056211554234311449330562472.2685.6534.9-854.6
Net Income Ratio 0.0010.0260.0370.0310.0530.0330.0540.0530.0470.0550.060.0460.0560.060.0630.0710.0150.0630.070.0970.0790.036-0.0210.0520.0490.0940.060.0540.0560.0110.030.0170.0220.0310.0240.0490000
EPS 1.2217.5721.6615.8923.1713.5810.698.927.318.177.975.285.74.654.694.751.053.943.494.253.511.51-0.942.081.963.042.041.641.540.320.850.360.480.70.480.780.670.960.78-1.38
EPS Diluted 1.2217.3921.315.7522.9613.4410.549.177.198.047.835.185.614.594.654.731.053.873.434.173.481.5-1.062.081.9532.021.631.540.320.850.360.480.70.480.780.670.960.78-1.38
EBITDA 9,4179,57412,90810,41314,47710,9164,0824,1873,47238,29535,50232,9773,4342,5082,3432,0733511,7801,8951,9902,0981,149-5701,5061,7302,2942,1101,7261,601251805165153580364696570.1833700.9-854.9
EBITDA Ratio 0.0380.0510.0690.0650.072-0.6040.0980.1050.0910.1040.1120.0940.1040.1140.110.1180.0330.1030.1170.1420.1360.064-0.0180.0910.0870.1340.1090.0950.0840.0130.0440.0120.0110.0410.0260.0610000